Recombinant baculovirus strategy for coexpression of functional human cytochrome P450 and P450 reductase.
Lee
C A
CA
Agouron Pharmaceuticals Inc., San Diego, California 92121, USA.
Kost
T A
TA
Serabjit-Singh
C J
CJ
D000818:Animals; D016367:Baculoviridae / Q000235:genetics; D019149:Bioreactors; D002460:Cell Line; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis / Q000235:genetics* / Q000302:isolation & purification; D015870:Gene Expression; D006801:Humans; D007313:Insecta; D008861:Microsomes / Q000201:enzymology; D009247:NADH, NADPH Oxidoreductases / Q000096:biosynthesis / Q000235:genetics* / Q000302:isolation & purification; D009251:NADPH-Ferrihemoprotein Reductase; D010957:Plasmids / Q000235:genetics; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000235:genetics / Q000302:isolation & purification; D018411:Spodoptera; D014773:Virology / Q000379:methods
D011994:Recombinant Proteins; D003577:Cytochrome P-450 Enzyme System; D009247:NADH, NADPH Oxidoreductases; D009251:NADPH-Ferrihemoprotein Reductase